SQUIRE PATTON BOGGS for GENENTECH, INC.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 18, 2012 | $90,000 | Replaced |
| 4th Quarter - Amendment (this page) | Apr 19, 2012 | $90,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY12 appropriations process, including H.R. 2112 and various Continuing Resolutions: FDA funding issues and drug approval/review oversight process. Monitor tax and healthcare policy changes in Super Committee negotiations.
Foreign entity interest: same as client
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN O'NEILL | — |
| MANNY ROSSMAN | Staff,Crane,01-04;Staff,Lott,05-06;Ofce,Whip,07-09 |
Medical/Disease Research/Clinical Labs MED
Implementation of healthcare reform law. FDA Drug Approval and appeal oversight process. Issues related to patient and physician choice in medical treatments. PATIENTS Act (S.660)
Foreign entity interest: same as client
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN O'NEILL | — |
| MANNY ROSSMAN | Staff,Crane,01-04;Staff,Lott,05-06;Ofce,Whip,07-09 |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.